ImmusanT, a clinical-stage company developing Nexvax2®, a therapeutic vaccine intended to protect against the effects of gluten exposure while maintaining a gluten-free diet, presented data at the 2017 International Celiac Disease Symposium (ICDS) in Delhi, India for a potential blood test that could detect celiac disease with a single gluten challenge. This blood test could also […]
Accelerating diagnosis, treatments, and a cure for celiac disease and non-celiac gluten sensitivity through research, education, and advocacy.
Save the date for the University of Chicago Celiac Disease Center’s Annual Celiac Education Day on Saturday, October 21, 2017. Celiac Disease Foundation (CDF) is proud to be a co-sponsor of this important event and host a Patient Advocacy Workshop during the program. The program begins at 10:00 AM with a Q & A panel […]
Senators Lindsey Graham (R-SC), Bill Cassidy (R-LA), Dean Heller (R-NV), and Ron Johnson (R-WI) recently introduced legislation known as Graham-Cassidy to repeal and replace the Affordable Care Act (ACA). The hope of these lawmakers is to hold yet another vote on repeal before October 1st, so a simple majority (51 votes) is all that is […]
On September 18, 2017, Celiac Disease Foundation (CDF) representatives attended a Food and Drug Administration (FDA) meeting in White Oak, MD on the ongoing implementation of a benefit-risk framework to inform drug and medical device review and approval processes. Under legislative mandate, the FDA is seeking to formally incorporate the patient experience and perspective into […]
Celiac Disease Found to Be Underfunded By NIH Compared to Other Diseases
Celiac Disease Foundation Presents at the International Celiac Disease Symposium in New Delhi, India